Zhongnan Medical Journal Press

Home Results

A total of 18 result was found. Results that relate to Prostate

The role of interleukin-8 in the development and progression of prostate cancer

Published on New Medicine 2021,31(1):383-389.
4382 times 2257 times

Sheng WANG Xing-Yu XIONG Lu YANG

Prostate cancer Interleukin-8 Targeted therapy
Details
Recent advances in the application of patient-derived tumor xenograft models in prostate cancer

Published on New Medicine 2021,31(1):285-293.
7266 times 2664 times

Jian-Li DUAN Zheng CHEN Yu-Zhuo WANG

Prostate cancer PDX model Preclinical research Precision medicine
Details
Research progress of exosomes in the diagnosis and treatment of prostate cancer

Published on New Medicine 2021,31(1):132-137.
5113 times 2710 times

Li-Ming MA Li-Na GONG Yan LI

Exosomes Prostate cancer Diagnosis Treatment
Details
Efficacy and safety of transurethral plasmakinetic resection of prostate versus transurethral resection for benign prostatic hyperplasia: a systematic review and meta-analysis

Published on New Medicine 2021,31(1):115-131.
7848 times 3146 times

Yong-Bo WANG Si-Yu YAN Xing HUANG Xing-Pei GUO Yu-Qing DENG Jia-Ao LOU Jia-Min GU Ying-Hui JIN Xiao-Dong LI Xian-Tao ZENG

Transurethral Plasmakinetic Resection of Prostate Transurethral Resection Prostate Benign prostate hyperplasia Randomized controlled trial
Details
Efficacy and safety of transurethral plasmakinetic resection of prostate versus transurethral plasmakinetic enucleation of prostate in treating benign prostate hyperplasia: a systematic review and Meta-analysis

Published on New Medicine 2021,31(1):100-114.
7873 times 2764 times

Xu-Hui LI Hao ZI Xing HUANG Yong-Bo WANG Si-Yu YAN Jia-Ao LOU Yu-Qing DENG Lu-Yao LI Cong ZHU Ying-Hui JIN Xiao-Dong LI Xian-Tao ZENG

Benign prostate hyperplasia Transurethral plasmakinetic resection of prostate Transurethral plasmakinetic enucleation of prostate Systematic review Meta-analysis
Details
Complications of transurethral plasmakinetic resection of prostate: a systematic review and meta-analysis

Published on New Medicine 2021,31(1):88-99.
6096 times 3155 times

Bing-Hui LI Shi-Di TANG Yong-Bo WANG Si-Yu YAN Jia-Ao LOU Yu-Qing DENG Tong DENG Ying-Hui JIN Xiao-Dong LI Xian-Tao ZENG

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Complications Incidence Systematic review Meta-analysis
Details
Research progress of estrogen receptor on prostate cancer

Published on New Medicine 2020,30(1):320-327.
16533 times 3092 times

Gang-Lin SU Kun HU Jun-Wen XIAO Yu-Chen LIU

Prostate cancer Estrogen receptor Oncogene
Details
Analysis of the burden of prostate cancer in China in 1990 and 2017

Published on New Medicine 2020,30(1):252-259.
8058 times 3298 times

Tong DENG Lin CAI Zheng CHEN Jia GUO Xing HUANG Chang-Xing KE Wen-Zhi LI Li JIANG Guan-Jun LU Xiao-Qiang LIU Jin-Hai FAN Xian-Tao ZENG

Prostate cancer Incidence Mortality Burden of disease Disability-adjusted life years
Details
Efficacy and safety of Shenqi Fuzheng injection combined with docetaxel treatment regime in patients with metastatic castration-resistant prostate cancer

Published on Frontiers in Pharmaceutical Sciences 2023,36(11):272-278.
1145 times 405 times

Xu-Hui CUI Ming WANG Lu ZHANG

Metastatic castration-resistant prostate cancer Shenqi Fuzheng injection Docetaxel Efficay Safety
Details
Mechanism of the medicine pair of Ezhu-Sanleng in the treatment of prostate cancer based on network pharmacology and molecular docking

Published on Journal of Mathematical Medicine 2024,37(1):22-33.
1692 times 853 times

ZHANG Die LIU Zengjing MENG Qiuxia WANG Huifeng HU Yanling1

Ezhu-Sanleng Medicine pair Prostate cancer Network pharmacology Molecular docking
Details
Mechanism research of PI3K/AKT pathway regulating PHF19 gene expression in prostate cancer

Published on New Medicine 2024,34(2):121-128.
1146 times 1445 times

MING Daojing GUO Mengmeng ZHANG Jinhui LIU Mengyang SHI Minghui LIU Shuyan YUAN Shuai ZENG Xiantao

PI3K/AKT TP63 PHF19 Prostate cancer
Details
The expression of ASXL3 in prostate cancer

Published on New Medicine 2024,34(3):282-290.
1049 times 907 times

ZHANG Jinhui LIU Mengyang CUI Jinlong REN Yiming CAI Yi MING Daojing REN Xuequn YUAN Shuai

ASXL3 Prostate cancer Prognosis Immune infiltration Biomarkers
Details
Cost-effectiveness analysis of enzalutamide in the treatment of metastatic prostate cancer

Published on Chinese Journal of Pharmacoepidemiology 2024,33(3):269-276.
1031 times 519 times

YANG Lei WANG Fengling HUANG Ling LI Yan ZHENG Hanrui ZHENG Lingli CHEN Li

Enzalutamide Metastatic prostate cancer Markov model Cost-effectiveness analysis
Details
Efficacy and safety of Chinese patent medicine in the treatment of benign prostatic hyperplasia: a Bayesian network Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(3):301-318.
1130 times 1074 times

MA Jia XING Jianyue ZHANG Yupeng LIU Guangzhen

Chinese patent medicine Benign prostate hyperplasia Bayesian network Meta-analysis Randomized controlled trial
Details
Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Published on New Medicine 2024,34(4):381-390.
2116 times 1412 times

LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases
Details